Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02652052 · ClinicalTrials.gov registry record · Phase 1

Hematopoietic Stem Cell Transplant Survivors Study

A Phase 1 study of Stem Cell Transplant, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
9
Enrollment target
1
Study location

NCT02652052: Completed Phase 1 study of Stem Cell Transplant, sponsored by Mayo Clinic.

NCT02652052 is a Phase 1 study of Stem Cell Transplant that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants, below the 195-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02652052, a Phase 1 study of Stem Cell Transplant, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis.

Conditions Studied

Stem Cell Transplant

Interventions

  • OTHER Standard of Care - Observation Only
  • DRUG Group 2: Quercetin
  • DRUG Group 2: Dasatinib

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2016-03-01
Est. Completion 2023-05-23
Phase Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02652052

The ClinicalTrials.gov registry entry for NCT02652052 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 195-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stem Cell Transplant appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care - Observation Only is the first listed.

NCT02652052 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02652052 about?

NCT02652052 is a clinical study titled "Hematopoietic Stem Cell Transplant Survivors Study". The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis.

What is the current status of trial NCT02652052?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2016-03-01. Estimated completion is 2023-05-23.

What conditions does trial NCT02652052 study?

This clinical trial studies the following conditions: Stem Cell Transplant.

What interventions are being tested in trial NCT02652052?

The interventions under investigation include: Standard of Care - Observation Only (OTHER), Group 2: Quercetin (DRUG), Group 2: Dasatinib (DRUG).

Who is sponsoring clinical trial NCT02652052?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02652052 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stem Cell Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stem Cell Transplant

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.